Dearborn Partners LLC Purchases Shares of 413,919 Corteva, Inc. $CTVA

Dearborn Partners LLC acquired a new stake in Corteva, Inc. (NYSE:CTVA - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 413,919 shares of the company's stock, valued at approximately $34,649,000. Corteva accounts for 1.8% of Dearborn Partners LLC's holdings, making the stock its 11th biggest holding. Dearborn Partners LLC owned 0.06% of Corteva as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Corteva by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company's stock valued at $5,398,392,000 after purchasing an additional 317,538 shares during the last quarter. BlackRock Inc. purchased a new stake in shares of Corteva during the 2nd quarter worth $4,560,180,000. State Street Corp grew its stake in shares of Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company's stock worth $2,451,346,000 after purchasing an additional 1,290,071 shares in the last quarter. Franklin Resources Inc. grew its stake in shares of Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company's stock worth $1,309,599,000 after purchasing an additional 805,873 shares in the last quarter. Finally, Harris Associates L P increased its holdings in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company's stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Stock Performance

NYSE CTVA opened at $82.74 on Tuesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a market capitalization of $55.21 billion, a PE ratio of 54.80, a P/E/G ratio of 2.51 and a beta of 0.57. The company has a fifty day moving average of $82.27 and a two-hundred day moving average of $80.32.

Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion for the quarter, compared to analysts' expectations of $6.60 billion. During the same quarter in the previous year, the firm earned $2.20 earnings per share. The business's revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva's dividend payout ratio (DPR) is currently 47.68%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of recent analyst reports. Royal Bank Of Canada lifted their price target on Corteva from $97.00 to $103.00 and gave the stock an "outperform" rating in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. Morgan Stanley raised their target price on Corteva from $84.00 to $95.00 and gave the stock an "overweight" rating in a research report on Thursday, May 28th. Rothschild & Co Redburn boosted their target price on Corteva from $80.00 to $90.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 29th. Finally, Oppenheimer upped their price target on Corteva from $89.00 to $95.00 and gave the company an "outperform" rating in a report on Thursday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $91.50.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source